Seed CR - Search Results

1

Hepatitis E virus RNA in Australian blood donations.

Shrestha AC, Flower RL, Seed CR, Keller AJ, Harley R, Chan HT, Hoad V, Warrilow D, Northill J, Holmberg JA, Faddy HM. Shrestha AC, et al. Among authors: seed cr. Transfusion. 2016 Dec;56(12):3086-3093. doi: 10.1111/trf.13799. Epub 2016 Sep 25. Transfusion. 2016. PMID: 27667133

2

Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey.

McOmish F, Yap PL, Dow BC, Follett EA, Seed C, Keller AJ, Cobain TJ, Krusius T, Kolho E, Naukkarinen R, et al. McOmish F, et al. J Clin Microbiol. 1994 Apr;32(4):884-92. doi: 10.1128/jcm.32.4.884-892.1994. J Clin Microbiol. 1994. PMID: 7913097 Free PMC article.

3

Variant Creutzfeldt-Jakob disease in Australian blood donors: estimation of risk and the impact of deferral strategies.

Correll PK, Law MG, Seed CR, Gust A, Buring M, Dax EM, Keller AJ, Kaldor JM. Correll PK, et al. Among authors: seed cr. Vox Sang. 2001 Jul;81(1):6-11. doi: 10.1046/j.1423-0410.2001.00056.x. Vox Sang. 2001. PMID: 11520409

4

Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT.

Seed CR, Cheng A, Ismay SL, Bolton WV, Kiely P, Cobain TJ, Keller AJ; Virology Subcommittee of the National Donor and Product Safety Committee, Australian Red Cross Blood Service. Seed CR, et al. Transfusion. 2002 Oct;42(10):1365-72. doi: 10.1046/j.1537-2995.2002.00204.x. Transfusion. 2002. PMID: 12423522

5

Nucleic acid technology screening of Australian blood donors for hepatitis C and human immunodeficiency virus-1 RNA: comparison of two high-throughput testing strategies.

Mison L, Seed CR, Margaritis AR, Hyland C; Australian Red Cross Blood Service Nucleic Acid Technology Study Group. Mison L, et al. Among authors: seed cr. Vox Sang. 2003 Jan;84(1):11-9. doi: 10.1046/j.1423-0410.2003.00246.x. Vox Sang. 2003. PMID: 12542729

6

Improved efficiency of national HIV, HCV, and HTLV antibody testing algorithms based on sequential screening immunoassays.

Seed CR, Margaritis AR, Bolton WV, Kiely P, Parker S, Piscitelli L; Virology Subcommittee of the National Donor and Product Safety Committee, Australian Red Cross Blood Service. Seed CR, et al. Transfusion. 2003 Feb;43(2):226-34. doi: 10.1046/j.1537-2995.2003.00304.x. Transfusion. 2003. PMID: 12559018

7

Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests.

Hyland C, Seed CR, Kiely P, Parker S, Cowley N, Bolton W. Hyland C, et al. Among authors: seed cr. Vox Sang. 2003 Jul;85(1):1-8. doi: 10.1046/j.1423-0410.2003.00316.x. Vox Sang. 2003. PMID: 12823724

8

The efficacy of a malarial antibody enzyme immunoassay for establishing the reinstatement status of blood donors potentially exposed to malaria.

Seed CR, Cheng A, Davis TM, Bolton WV, Keller AJ, Kitchen A, Cobain TJ. Seed CR, et al. Vox Sang. 2005 Feb;88(2):98-106. doi: 10.1111/j.1423-0410.2005.00605.x. Vox Sang. 2005. PMID: 15720607

9

The current status and potential role of laboratory testing to prevent transfusion-transmitted malaria.

Seed CR, Kitchen A, Davis TM. Seed CR, et al. Transfus Med Rev. 2005 Jul;19(3):229-40. doi: 10.1016/j.tmrv.2005.02.004. Transfus Med Rev. 2005. PMID: 16010653 Review.

10

Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.

Seed CR, Kiely P, Keller AJ. Seed CR, et al. Intern Med J. 2005 Oct;35(10):592-8. doi: 10.1111/j.1445-5994.2005.00926.x. Intern Med J. 2005. PMID: 16207258

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page